FdaApplication
BLA 125812
Identifiers
- fda_app_no: BLA125812
Properties
| Property | Value |
|---|---|
| applicant_name | Humacyte Global Inc. |
| application_type | BLA |
| approval_date | 2024-12-19 |
Revenue by product
SYMVESS
| Period | Revenue |
|---|---|
| Q2 2025 | $0.1M |
Revenue as this company reported it for this product. A combination product's amount is stated once, for the product, and never divided across its ingredients.
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SYMVESS | — | 6 MM IN INNER DIAMETER,~42 CM LENGTH | Implant |
1 product